Literature DB >> 7753620

Detection of platinum-DNA adducts by 32P-postlabelling.

F A Blommaert1, C P Saris.   

Abstract

We developed a sensitive 32P-postlabeling method for the detection of bifunctional intrastrand crosslinks d(Pt-GpG) and d(Pt-ApG) in DNA in vitro and in vivo. After enzymatic digestion of DNA the positively charged platinum adducts were purified from unplatinated products, using strong cation exchange chromatography. Subsequently the samples were deplatinated with cyanide, because platinated dinucleotides are very poor substrates for polynucleotide kinase. The excess of cyanide was removed using Sep-pak C18 cartridges, and the resulting dinucleoside monophosphates d(GpG) and d(ApG) were subsequently postlabelled. Analysis of the postlabelling mixture was performed by a combined TLC and HPLC-procedure. Good correlations with existing methods (AAS, immunocytochemistry and ELISA) were found in DNA samples treated in vitro and in vivo with cis- or carboplatin. The detection limit of the assay was 1 adduct/10(7) nucleotides in a 10 micrograms DNA sample.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7753620      PMCID: PMC306853          DOI: 10.1093/nar/23.8.1300

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  29 in total

1.  A polymerase chain reaction-based method to detect cisplatin adducts in specific genes.

Authors:  M M Jennerwein; A Eastman
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

2.  Immunocytochemical detection of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in rodent tissue sections.

Authors:  P M Terheggen; B G Floot; E Scherer; A C Begg; A M Fichtinger-Schepman; L den Engelse
Journal:  Cancer Res       Date:  1987-12-15       Impact factor: 12.701

Review 3.  Resistance to cisplatin and analogues: mechanisms and potential clinical implications.

Authors:  A de Graeff; R J Slebos; S Rodenhuis
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

4.  Influence of the degree of DNA modification on the immunochemical determination of cisplatin-DNA adduct levels.

Authors:  A M Fichtinger-Schepman; R A Baan; F Berends
Journal:  Carcinogenesis       Date:  1989-12       Impact factor: 4.944

5.  Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNA.

Authors:  A Eastman
Journal:  Biochemistry       Date:  1986-07-01       Impact factor: 3.162

6.  cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II).

Authors:  A M Fichtinger-Schepman; A T van Oosterom; P H Lohman; F Berends
Journal:  Cancer Res       Date:  1987-06-01       Impact factor: 12.701

7.  Formation and repair of DNA interstrand cross-links in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum(II).

Authors:  A C Plooy; M van Dijk; F Berends; P H Lohman
Journal:  Cancer Res       Date:  1985-09       Impact factor: 12.701

8.  32P-labeling test for DNA damage.

Authors:  K Randerath; M V Reddy; R C Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

9.  Immunochemical quantitation of adducts induced in DNA by cis-diamminedichloroplatinum (II) and analysis of adduct-related DNA-unwinding.

Authors:  A M Fichtinger-Schepman; R A Baan; A Luiten-Schuite; M van Dijk; P H Lohman
Journal:  Chem Biol Interact       Date:  1985-11       Impact factor: 5.192

10.  Polyclonal antibodies to quantitate cis-diamminedichloroplatinum(II)--DNA adducts in cancer patients and animal models.

Authors:  M C Poirier; E Reed; L A Zwelling; R F Ozols; C L Litterst; S H Yuspa
Journal:  Environ Health Perspect       Date:  1985-10       Impact factor: 9.031

View more
  9 in total

1.  A microdosing approach for characterizing formation and repair of carboplatin-DNA monoadducts and chemoresistance.

Authors:  Paul T Henderson; Tao Li; Miaoling He; Hongyong Zhang; Michael Malfatti; David Gandara; Peter P Grimminger; Kathleen D Danenberg; Laurel Beckett; Ralph W de Vere White; Kenneth W Turteltaub; Chong-Xian Pan
Journal:  Int J Cancer       Date:  2011-03-04       Impact factor: 7.396

2.  Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells.

Authors:  R C Rietbroek; P J van de Vaart; J Haveman; F A Blommaert; A Geerdink; P J Bakker; C H Veenhof
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

3.  Transplatin-conjugated triplex-forming oligonucleotides form adducts with both strands of DNA.

Authors:  Meghan A Campbell; Paul S Miller
Journal:  Bioconjug Chem       Date:  2009-12       Impact factor: 4.774

4.  Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death.

Authors:  Stefania Gonfloni; Lucia Di Tella; Sara Caldarola; Stefano M Cannata; Francesca G Klinger; Claudia Di Bartolomeo; Maurizio Mattei; Eleonora Candi; Massimo De Felici; Gerry Melino; Gianni Cesareni
Journal:  Nat Med       Date:  2009-09-27       Impact factor: 53.440

5.  Cross-linking to an interrupted polypurine sequence with a platinum-modified triplex-forming oligonucleotide.

Authors:  Meghan A Campbell; Paul S Miller
Journal:  J Biol Inorg Chem       Date:  2009-04-07       Impact factor: 3.358

6.  Development of an ultraperformance liquid chromatography/mass spectrometry method to quantify cisplatin 1,2 intrastrand guanine-guanine adducts.

Authors:  Irene M Baskerville-Abraham; Gunnar Boysen; J Mitchell Troutman; Esra Mutlu; Leonard Collins; Kathryn E Dekrafft; Wenbin Lin; Candice King; Stephen G Chaney; James A Swenberg
Journal:  Chem Res Toxicol       Date:  2009-05       Impact factor: 3.739

Review 7.  Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer.

Authors:  George D Cimino; Chong-xian Pan; Paul T Henderson
Journal:  Bioanalysis       Date:  2013-02       Impact factor: 2.681

8.  Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei.

Authors:  Bernd Liedert; Dick Pluim; Jan Schellens; Jürgen Thomale
Journal:  Nucleic Acids Res       Date:  2006-03-29       Impact factor: 16.971

9.  3D-DIP-Chip: a microarray-based method to measure genomic DNA damage.

Authors:  James Rees Powell; Mark Richard Bennett; Katie Ellen Evans; Shirong Yu; Richard Michael Webster; Raymond Waters; Nigel Skinner; Simon Huw Reed
Journal:  Sci Rep       Date:  2015-01-22       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.